Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Melitracen hydrochloride crystal form A and preparation method thereof

A technology of melitracen hydrochloride and melitracen hydrochloride, which is applied in the field of medicinal chemistry, can solve the problems affecting the efficacy and safety of drugs, different melting points, solubility and stability, affecting the absorption and release of drugs, etc., and achieves suitable industrial production. , good stability and solubility, good druggability effect

Inactive Publication Date: 2018-03-09
NHWA PHARMA CORPORATION
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] It is generally believed that polymorphic drugs, due to different crystal forms, may have different melting points, solubility, stability, etc., which will affect the absorption and release of drugs in the body, thereby affecting the efficacy and safety of drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Melitracen hydrochloride crystal form A and preparation method thereof
  • Melitracen hydrochloride crystal form A and preparation method thereof
  • Melitracen hydrochloride crystal form A and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Weigh 1 g of melitracen hydrochloride sample, put it into an eggplant-shaped bottle, add 10 ml of 95% ethanol, and remove the solvent by rotary evaporation under reduced pressure at a vacuum of 0.09 MPa and 45°C, collect the solid, and dry it overnight at 60°C to obtain melitracen hydrochloride Trisine crystal form A. The purity is 99.8%, X-ray powder diffraction as figure 1 shown.

Embodiment 2

[0052] Weigh 1 g of melitracen hydrochloride sample, put it into an eggplant-shaped bottle, add 10 ml of 90% ethanol, and remove the solvent by rotary evaporation at a vacuum of 0.09 MPa and 60°C, collect the solid, and dry it overnight at 50°C to obtain melitracen hydrochloride. Trisine crystal form A.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a new crystal form A of melitracen hydrochloride, wherein an X-ray powder diffraction spectrum of the crystal form A expressed by a diffraction angle of 2theta + / -0.2 degrees shows characteristic peaks at 10.467, 11.361, 11.812, 13.895, 15.785, 16.602, 17.419, 18.696, 21.133, 21.691 and 24.370.

Description

Technical field: [0001] The invention relates to the field of medicinal chemistry, in particular to a crystal form A of melitracen hydrochloride and a preparation method thereof. Background technique: [0002] Melitracen hydrochloride (Melitracen hydrochloride) has a chemical name of 3-[10,10-dimethyl-9(10H)-anthracene]-N,N-dimethylpropylamine hydrochloride; 3-[10 ,10-Dimethyl-9(10H)-anthrylene]-N,N-dimethylpropylamine hydrochloride, CAS No.: 10563-70-9. Melitracen hydrochloride can inhibit the reuptake of norepinephrine in the presynaptic membrane and increase the content of synaptic monoamine transmitters. This product was launched in the market in 1968. It is used in combination with flupenthixol. It has the function of synergistically regulating the central nervous system, exerts antidepressant, anti-anxiety and excitatory properties, and is suitable for acute and chronic schizophrenia and depression. [0003] The structural formula is as follows: [0004] [0005]...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C209/84C07C211/31
CPCC07C209/84C07B2200/13C07C211/31C07C2603/24
Inventor 郝超王国海陈亮张桂森
Owner NHWA PHARMA CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products